By Alex Sirois May 11, 2021 ... MVIS Stock Predictions, Articles, and Microvision News On average, they anticipate BioXcel Therapeutics' stock price to reach $101.36 in the next twelve months. There are currently 11 buy ratings for the stock. About the Volkswagen AG stock forecast. (BTAI) raised $60 million in an IPO on Thursday, March 8th 2018. The P/E ratio of BioXcel Therapeutics is -9.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. BTAI stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Goldman Sachs Group Inc., Millennium Management LLC, Credit Suisse AG, Logos Global Management LP, Northern Trust Corp, Massachusetts Financial Services Co. MA, and State of Wisconsin Investment Board. View our earnings forecast for BioXcel Therapeutics. BioXcel Therapeutics does not have a long track record of dividend growth. View analyst ratings for BioXcel Therapeutics or view top-rated stocks. Looking for new stock ideas? ... (ETH) Price Predictions… Their forecasts range from $60.00 to $170.00. BioXcel Therapeutics employs 50 workers across the globe. About the STMicroelectronics NV stock forecast. Receive a free world-class investing education from MarketBeat. View insider buying and selling activity for BioXcel Therapeutics or or view top insider-buying stocks. ), BioXcel Therapeutics has received 171 “underperform” votes. MVIS stock forecast As MVIS was a penny stock before this recent rally began, not many analysts cover it. Their forecasts range from $11.00 to $13.00. It offers its product under the PicoP brand. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. MVIS - MicroVision Inc. The stock is up 244 percent YTD and … This suggests a possible upside of 210.3% from the stock's current price. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. About the MicroVision, Inc. stock forecast. Cookie Notice (). Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. BioXcel Therapeutics has only been the subject of 4 research reports in the past 90 days. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Skip to main content S&P 500 4,112.50 (+1.22%) Shares of BTAI can be purchased through any online brokerage account. I bought at 20. As of 2021 May 14, Friday current price of VWAGY stock is 32.140$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Volkswagen AG stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. Company insiders that own BioXcel Therapeutics stock include Frank Yocca, Peter Mueller, Vimal Mehta and Vincent O'neill. MicroVision (MVIS) stock soared over 50 percent on March 31, but it was trading lower in pre-market trading on April 1. Holder Shares Date Reported % Out Value; Vanguard Total Stock Market Index Fund: 4,134,096: Dec 30, 2020: 2.62%: 22,241,436: Vanguard Extended Market Index Fund You can opt out at any time. Historical and current end-of-day data provided by FACTSET. View BioXcel Therapeutics' earnings history. Executive Summary. About the Nautilus, Inc. stock forecast. Over the past 90 days, the Zacks Consensus Estimate for MVIS's full-year earnings has moved 43.33% higher. The company can be reached via phone at 475-238-6837 or via email at [email protected]. Have Watchlists? Since then, BTAI stock has increased by 7.5% and is now trading at $31.69. PicoP scanning technology has addressing the following market segments Interactive and non-interactive projected displays, 3D Perceptive LiDAR sensing for consumer electronics, Augmented/Mixed Reality (AR/MR) and 3D Perceptive LiDAR sensing for automotive active collision avoidance. Something went wrong while loading Watchlist. Intraday data delayed at least 15 minutes or per exchange requirements. Vote “Underperform” if you believe BTAI will underperform the S&P 500 over the long term. Once you see our Nio stock price prediction for 2025, you'll know why. © American Consumer News, LLC dba MarketBeat® 2010-2021. 2d ago Top 20 Trending Stocks On WallStreetBets As Of Monday, Apr. Its Tron (TRX) price prediction for 2025 is 76 cents, and it says Tron could climb to $1.00 by the end of 2030. This will be for vehicles with 2025 production targets and beyond. There are currently no items in this Watchlist. Export data to Excel for your own analysis. BioXcel Therapeutics is headquartered at 555 LONG WHARF DRIVE, NEW HAVEN CT, 06511. On average, they expect Himax Technologies' share price to reach $12.00 in the next year. Admittedly, I follow WSB since the gamestop thing and initially came here because I saw it was linked to WSB. But that might not be giving Nio enough credit. Seanergy Maritime Holdings Stock Forecast, SHIP stock price prediction. This browser is no longer supported at MarketWatch. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Our Accessibility Statement | Terms of Service | Do Not Sell My Information. 4 brokerages have issued 12 month target prices for Himax Technologies' shares. The company reported ($1.08) EPS for the quarter, missing analysts' consensus estimates of ($0.89) by $0.19. BioXcel Therapeutics, Inc. (NASDAQ:BTAI) posted its earnings results on Sunday, May, 9th. As of 2021 May 12, Wednesday current price of STM stock is 36.560$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. ST Microelectronics - New York Shares stock price as been showing a rising tendency so we believe that similar market segments were very popular in the given time frame. The stock price of MicroVision - a leader in MEMS-based laser beam sensing technology - is trading at over 40% pre-market. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. About the CRISPR Therapeutics AG stock forecast. Get daily stock ideas top-performing Wall Street analysts. View all of BTAI's competitors. Create a list of the investments you want to track. Microvision Inc. Stock Forecast, "MVIS" Stock Predictons by days: 2025 Get Our PREMIUM Forecast Now, from ONLY $7.49! Next reporting date: August 4, 2021: EPS forecast (this quarter)-$0.06: Annual revenue (last year) $3.1M: Annual profit (last year)-$13.6M: Net profit margin